Advanced Animal Replacement Testing Strategies Using Stem Cell and Organoids.

Area of Science:

• Biotechnology and Regenerative Medicine
• Toxicology and Pharmacology
• Regulatory Science

Background:

• Growing ethical concerns and regulatory restrictions on animal testing necessitate advanced alternatives.
• Stem cell-based systems and organoids are emerging as key in vitro models for human physiology.
• Technological advancements are driving the development and adoption of these novel models.

Purpose of the Study:

• To review trends and driving factors for adopting stem cell and organoid models.
• To explore the development and application of various in vitro model systems.
• To highlight the potential of these models in replacing animal testing for preclinical applications.

Main Methods:

• Review of technological advancements in stem cell and organoid development.
• Analysis of regulatory support from agencies like the OECD and FDA.
• Examination of 3D reconstructed tissues, iPSC-derived cells, and microphysiological systems.

Main Results:

• Stem cell and organoid models provide ethical, scalable, and physiologically relevant alternatives.
• These models show potential in toxicity evaluation, disease modeling, and drug development.
• Quality control and standardization are crucial for regulatory acceptance and reproducibility.

Conclusions:

• Innovative in vitro models represent a transformative step towards reducing animal use.
• Organ-specific evaluation methods enhance toxicity and efficacy assessments.
• Despite challenges, these models promise improved relevance and reliability in preclinical testing.